We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+10.37%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$6.31B
AUM Growth
+$553M
Cap. Flow
+$7.17M
Cap. Flow %
0.11%
Top 10 Hldgs %
38.54%
Holding
691
New
7
Increased
60
Reduced
171
Closed
20

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$21M
2
CRM icon
Salesforce
CRM
+$15.4M
3
BDX icon
Becton Dickinson
BDX
+$15.3M
4
AMT icon
American Tower
AMT
+$9.87M
5
HDB icon
HDFC Bank
HDB
+$9.45M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.8M
2
RTX icon
RTX Corp
RTX
+$9.58M
3
CL icon
Colgate-Palmolive
CL
+$8.83M
4
AYI icon
Acuity Brands
AYI
+$6.25M
5
SBUX icon
Starbucks
SBUX
+$5.95M

Sector Composition

Rank Sector Weight
1 Technology 30.1%
2 Healthcare 18.05%
3 Financials 10.56%
4 Consumer Discretionary 9.68%
5 Consumer Staples 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TM icon
451
Toyota
TM
$223B
$36K ﹤0.01%
290
NWN icon
452
Northwest Natural Holdings
NWN
$2.14B
$35K ﹤0.01%
530
-20
-4% -$1.31K
HAL icon
453
Halliburton
HAL
$27.6B
$34K ﹤0.01%
840
-32
-4% -$1.32K
DISCB
454
DELISTED
Discovery, Inc. Series B Common Stock
DISCB
$34K ﹤0.01%
1,000
SHPG
455
DELISTED
Shire pic
SHPG
$33K ﹤0.01%
181
PETS icon
456
PetMed Express
PETS
$42.1M
$32K ﹤0.01%
975
WOLF icon
457
Wolfspeed
WOLF
$1.65B
$32K ﹤0.01%
840
+440
+110% +$20K
EPZM
458
DELISTED
Epizyme, Inc
EPZM
$32K ﹤0.01%
3,000
BXP icon
459
Boston Properties
BXP
$11B
$31K ﹤0.01%
250
SCZ icon
460
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$31K ﹤0.01%
500
GWW icon
461
W.W. Grainger
GWW
$61.6B
$30K ﹤0.01%
85
LBTYA icon
462
Liberty Global Class A
LBTYA
$3.51B
$30K ﹤0.01%
1,031
DATA
463
DELISTED
Tableau Software, Inc.
DATA
$30K ﹤0.01%
265
CAH icon
464
Cardinal Health
CAH
$53.9B
$29K ﹤0.01%
530
UAA icon
465
Under Armour
UAA
$2.29B
$29K ﹤0.01%
1,375
WDAY icon
466
Workday
WDAY
$43.4B
$29K ﹤0.01%
200
KBE icon
467
State Street SPDR S&P Bank ETF
KBE
$1.75B
$28K ﹤0.01%
600
MS icon
468
Morgan Stanley
MS
$345B
$28K ﹤0.01%
600
-600
-50% -$29.3K
MTRN icon
469
Materion
MTRN
$5.98B
$28K ﹤0.01%
457
PKG icon
470
Packaging Corp of America
PKG
$22.9B
$28K ﹤0.01%
255
CRSP icon
471
CRISPR Therapeutics
CRSP
$5.2B
$27K ﹤0.01%
600
CATC
472
DELISTED
CAMBRIDGE BANCORP
CATC
$27K ﹤0.01%
300
LOGM
473
DELISTED
LogMein, Inc.
LOGM
$27K ﹤0.01%
300
AKAM icon
474
Akamai
AKAM
$17.9B
$26K ﹤0.01%
350
BME icon
475
BlackRock Health Sciences Trust
BME
$577M
$26K ﹤0.01%
600

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Loring Wolcott & Coolidge Fiduciary Advisors held 691 positions worth $6.31B, up 9.6% from $5.76B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3.9%. Loring Wolcott & Coolidge Fiduciary Advisors opened 7 new positions and exited 20, leaving the 691-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q3 2018 buy was Vanguard FTSE Developed Markets ETF: 16,287 shares worth $705K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to NXP Semiconductors in Q3 2018, an estimated $21M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $10.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Invesco FTSE International Low Beta Equal Weight ETF in Q3 2018, selling an estimated $910K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 39% of its $6.31B portfolio in Q3 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 7 new positions and closed 20 in Q3 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 9.6% quarter-over-quarter to $6.31B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2018, filed 31 Oct 2018.